investment in Rivian had a fair value of $15.6 billion and $2.9 billion as of December 31, 2021 and December 31, 2022, respectively. The investment was subject to regulatory sales restrictions resulting in a discount for lack of marketability of approximately $800 million as of December 31, 2021, which expired in Q1 2022. The following table summarizes gross gains and gross losses realized on sales of marketable fixed income securities (in millions): Year Ended December 31, 2020 2021 2022 Realized gains $ 92 $ 85 $ 43 Realized losses 56 38 341 The following table summarizes the remaining contractual maturities